These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 1139583)
1. [Metabolism of copper and its disorders]. Hauftová D Cas Lek Cesk; 1975 Mar; 114(10-11):341-5. PubMed ID: 1139583 [No Abstract] [Full Text] [Related]
2. Investigations by the use of radioactive copper (64Cu) in chronic liver diseases. Wysocki K; Owczarek L; Górski S; Kurnatowska A Pol Med J; 1969; 8(1):43-9. PubMed ID: 5782169 [No Abstract] [Full Text] [Related]
3. The copper-controlled diet: current aspects of dietary copper restriction in management of copper metabolism disorders. Smithgall JM J Am Diet Assoc; 1985 May; 85(5):609-10. PubMed ID: 3886765 [No Abstract] [Full Text] [Related]
4. [Copper metabolism disorders as an attempt at explaining analogous pathological mechanisms in Wilson's syndrome and severe cases of liver cirrhosis]. Pawlak J Wiad Lek; 1975 Jun; 28(12):1041-4. PubMed ID: 1136474 [No Abstract] [Full Text] [Related]
5. Simultaneous use of two radioisotopes of copper (64Cu and 67Cu) in the study of copper turnover in man. Gibbs K; Walshe JM; Osborn SB Clin Sci; 1969 Dec; 37(3):877-8. PubMed ID: 5363591 [No Abstract] [Full Text] [Related]
6. Liver copper in health and disease. Epstein O Postgrad Med J; 1983; 59 Suppl 4():88-94. PubMed ID: 6647221 [No Abstract] [Full Text] [Related]
8. Copper transport and excretion in normal subjects and in patients with Laennec's cirrhosis and Wilson's disease: a study with CU64. JENSEN WN; KAMIN H J Lab Clin Med; 1957 Feb; 49(2):200-10. PubMed ID: 13398686 [No Abstract] [Full Text] [Related]
9. Copper metabolism in Wilson's disease, Laennec's cirrhosis and hemachromatosis: studies with radiocopper (Cu64). MAYTUM WJ; GOLDSTEIN NP; McGUCKIN WF; OWEN CA Proc Staff Meet Mayo Clin; 1961 Dec; 36():641-60. PubMed ID: 14471779 [No Abstract] [Full Text] [Related]
11. Pathology of the liver in copper overload. Johncilla M; Mitchell KA Semin Liver Dis; 2011 Aug; 31(3):239-44. PubMed ID: 21901654 [TBL] [Abstract][Full Text] [Related]
12. [Protein-copper complex in primary biliary cirrhosis and other chronic diffuse diseases of the liver]. Loginov AS; Aruin LI; Shepeleva SD Arkh Patol; 1980; 42(4):50-5. PubMed ID: 7396755 [TBL] [Abstract][Full Text] [Related]
14. The intrahepatic distribution of copper in relation to the pathogenesis of hepatolenticular degeneration. UZMAN LL AMA Arch Pathol; 1957 Oct; 64(4):464-79. PubMed ID: 13457604 [No Abstract] [Full Text] [Related]
15. [Features of the course and disorders of copper and ceruloplasmin metabolism in hepatolenticular degeneration]. Davidenkova EF; Neĭfakh SA; Butomo IV; Mashkov BA; Lapchenkov VI Zh Nevropatol Psikhiatr Im S S Korsakova; 1967; 67(7):982-90. PubMed ID: 5598796 [No Abstract] [Full Text] [Related]
16. Metallothionein and copper in liver disease. Elmes ME; Jasani B Lancet; 1987 Oct; 2(8563):866. PubMed ID: 2889077 [No Abstract] [Full Text] [Related]
17. [Juvenile cirrhosis with extreme copper storage in the liver. Clinical, histopathological, histochemical and electron microscopic studies]. Bartók I; Szabó L; Horváth E; Ormos J Acta Hepatosplenol; 1971; 18(2):119-28. PubMed ID: 5279689 [No Abstract] [Full Text] [Related]
18. The effect of drugs upon the copper metabolism in hepatolenticular degeneration and in normal subjects. ZIMDAHL WT; HYMAN I; STAFFORD WF J Lab Clin Med; 1954 May; 43(5):774-84. PubMed ID: 13163577 [No Abstract] [Full Text] [Related]